Fuan Pharmaceutical (Group) Co., Ltd.
SHZ: 300194.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Lu Wang
- Employees
- 3,292
- Headquarters
- Chongqing, China
- IPO year
- 2011
- Market cap
- CN¥4.9B
- Website
- https://www.fapharm.com
Loading 300194…
Loading profile data…Frequently asked questions about 300194
What does Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) do?
Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells pharmaceutical intermediates, bulk drugs, and formulations in the People's Republic of China. It offers APIs and intermediates, as well as formulations, such as anti-infective, cardiovascular, digestive, leaflet, and other prod...
Where does 300194.SZ trade?
Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300194.SZ in?
Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Fuan Pharmaceutical (Group) Co., Ltd.?
Lu Wang is the chief executive officer of Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ).
Where is Fuan Pharmaceutical (Group) Co., Ltd. headquartered?
Fuan Pharmaceutical (Group) Co., Ltd. is headquartered in China.
Does 300194.SZ pay a dividend?
Yes — Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) paid a trailing twelve-month dividend of CNY 0.07 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300194.SZ go public?
Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) completed its initial public offering in 2011.